InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
T+90 hit rate
88%
T+90 mean return
+17.5%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Ball Susan E, Directeur Juridique. Officer active across 1 company, notably Cross Country Healthcare INC. Aggregated, 17 reports have been recorded. Breakdown: 0 buy · 7 sells. Total volume traded: €2.4m. Activity tracked since 7 March 2022. The latest transaction was filed on 31 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations17 total
1,740 shares@ US$14.896.3% of flowCommon StockSEC:0001012975-26-000025
1,740 shares@ US$14.890.0059% mcap6.3% of flowCommon StockSEC:0001012975-26-000025:0
1,740 shares@ US$14.891.0% of flowCommon StockSEC:0001062993-25-006854:0
10,018 shares0Common StockSEC:0001062993-25-006079:0
15,358 shares0Common StockSEC:0001062993-24-007799:0
12,170 shares0Common StockSEC:0001062993-24-007360:0
5,441 shares@ US$21.574.4% of flowCommon StockSEC:0001062993-23-021326:0
9,559 shares@ US$21.017.6% of flowCommon StockSEC:0001062993-23-021372:0
12,881 shares0Common StockSEC:0001062993-23-008702:0
24,901 shares0Common StockSEC:0001062993-23-006551:0
14,901 shares@ US$30.0018.7% of flowCommon StockSEC:0001062993-22-020404:0
9,891 shares@ US$28.9411.7% of flowCommon StockSEC:0001062993-22-019792:0
15,230 shares@ US$28.9418.1% of flowCommon StockSEC:0001062993-22-019792:1
19,236 shares@ US$29.0622.9% of flowCommon StockSEC:0001062993-22-019792:2
13,268 shares0Common StockSEC:0001062993-22-009520:0
16,003 shares0Common StockSEC:0001062993-22-008952:0
17,458 shares@ US$20.720.082% mcap87.4% of flowCommon StockSEC:0001062993-22-007089:0
17 of 17 declarations
About Ball Susan E
Susan E. Ball is the General Counsel and Secretary of CROSS COUNTRY HEALTHCARE INC. She oversees the company's legal affairs, including compliance and litigation management, thereby ensuring the protection of the company's interests.
